A new study published in the Journal of the National Cancer Institue found that patients taking TZD (thiazolidinedione drugs, including Actos and Avandia) for more than five years had two to three times the incidence of bladder cancer as patients taking sulfonyurea (diabetes medication).
The study was performed by University of Pennsylvania researchers and is yet another link in the chain between bladder cancer and Actos.
Ronac Mamtani, MD, the head University of Pennsylvania researcher said that the stated that, “doctors who care for patients with diabetes should be very aware of any bladder-related symptoms patients might be having, like blood in the urine, and take steps to further evaluate those issues.”
If you have, or someone you know has, developed bladder cancer after taking Actos and you wish to discuss your legal rights, please contact the attorneys of Sheller, P.C. at 888-883-2299, or write us at firstname.lastname@example.org.